402 related articles for article (PubMed ID: 23747654)
1. Anti-inflammatory glucocorticoids: changing concepts.
Newton R
Eur J Pharmacol; 2014 Feb; 724():231-6. PubMed ID: 23747654
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory stimuli inhibit glucocorticoid-dependent transactivation in human pulmonary epithelial cells: rescue by long-acting beta2-adrenoceptor agonists.
Rider CF; King EM; Holden NS; Giembycz MA; Newton R
J Pharmacol Exp Ther; 2011 Sep; 338(3):860-9. PubMed ID: 21622733
[TBL] [Abstract][Full Text] [Related]
3. Glucocorticoid repression of inflammatory gene expression shows differential responsiveness by transactivation- and transrepression-dependent mechanisms.
King EM; Chivers JE; Rider CF; Minnich A; Giembycz MA; Newton R
PLoS One; 2013; 8(1):e53936. PubMed ID: 23349769
[TBL] [Abstract][Full Text] [Related]
4. Cytokine-induced loss of glucocorticoid function: effect of kinase inhibitors, long-acting β(2)-adrenoceptor [corrected] agonist and glucocorticoid receptor ligands.
Rider CF; Shah S; Miller-Larsson A; Giembycz MA; Newton R
PLoS One; 2015; 10(1):e0116773. PubMed ID: 25625944
[TBL] [Abstract][Full Text] [Related]
5. Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?
Newton R; Holden NS
Mol Pharmacol; 2007 Oct; 72(4):799-809. PubMed ID: 17622575
[TBL] [Abstract][Full Text] [Related]
6. How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering.
Ratman D; Vanden Berghe W; Dejager L; Libert C; Tavernier J; Beck IM; De Bosscher K
Mol Cell Endocrinol; 2013 Nov; 380(1-2):41-54. PubMed ID: 23267834
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung diseases.
Newton R; Leigh R; Giembycz MA
Pharmacol Ther; 2010 Feb; 125(2):286-327. PubMed ID: 19932713
[TBL] [Abstract][Full Text] [Related]
8. Modulation of transcriptional responses by poly(I:C) and human rhinovirus: effect of long-acting β₂-adrenoceptor agonists.
Rider CF; Miller-Larsson A; Proud D; Giembycz MA; Newton R
Eur J Pharmacol; 2013 May; 708(1-3):60-7. PubMed ID: 23523474
[TBL] [Abstract][Full Text] [Related]
9. Dissociated glucocorticoids with anti-inflammatory potential repress interleukin-6 gene expression by a nuclear factor-kappaB-dependent mechanism.
Vanden Berghe W; Francesconi E; De Bosscher K; Resche-Rigon M; Haegeman G
Mol Pharmacol; 1999 Oct; 56(4):797-806. PubMed ID: 10496964
[TBL] [Abstract][Full Text] [Related]
10. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo.
Vayssière BM; Dupont S; Choquart A; Petit F; Garcia T; Marchandeau C; Gronemeyer H; Resche-Rigon M
Mol Endocrinol; 1997 Aug; 11(9):1245-55. PubMed ID: 9259316
[TBL] [Abstract][Full Text] [Related]
11. Transrepression and transactivation potencies of inhaled glucocorticoids.
Dirks NL; Li S; Huth B; Hochhaus G; Yates CR; Meibohm B
Pharmazie; 2008 Dec; 63(12):893-8. PubMed ID: 19177906
[TBL] [Abstract][Full Text] [Related]
12. Effects of glucocorticoids on gene transcription.
Hayashi R; Wada H; Ito K; Adcock IM
Eur J Pharmacol; 2004 Oct; 500(1-3):51-62. PubMed ID: 15464020
[TBL] [Abstract][Full Text] [Related]
13. [Mechanisms of action of glucocorticoids].
Dejean C; Richard D
Rev Med Interne; 2013 May; 34(5):264-8. PubMed ID: 23498716
[TBL] [Abstract][Full Text] [Related]
14. New insights into the anti-inflammatory mechanisms of glucocorticoids: an emerging role for glucocorticoid-receptor-mediated transactivation.
Vandevyver S; Dejager L; Tuckermann J; Libert C
Endocrinology; 2013 Mar; 154(3):993-1007. PubMed ID: 23384835
[TBL] [Abstract][Full Text] [Related]
15. Endothelial cells present an innate resistance to glucocorticoid treatment: implications for therapy of primary vasculitis.
Koenen P; Barczyk K; Wolf M; Roth J; Viemann D
Ann Rheum Dis; 2012 May; 71(5):729-36. PubMed ID: 22203687
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the dissociated steroid RU24858 does not exclude a role for inducible genes in the anti-inflammatory actions of glucocorticoids.
Chivers JE; Gong W; King EM; Seybold J; Mak JC; Donnelly LE; Holden NS; Newton R
Mol Pharmacol; 2006 Dec; 70(6):2084-95. PubMed ID: 16988013
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory actions of glucocorticoids: molecular mechanisms.
Barnes PJ
Clin Sci (Lond); 1998 Jun; 94(6):557-72. PubMed ID: 9854452
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticosteroids.
Barnes PJ
Handb Exp Pharmacol; 2017; 237():93-115. PubMed ID: 27796513
[TBL] [Abstract][Full Text] [Related]
19. Corticosteroid effects on cell signalling.
Barnes PJ
Eur Respir J; 2006 Feb; 27(2):413-26. PubMed ID: 16452600
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of glucocorticoid action in mast cells.
Oppong E; Flink N; Cato AC
Mol Cell Endocrinol; 2013 Nov; 380(1-2):119-26. PubMed ID: 23707629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
